1. Differential sensitivity of normal and transformed human cells to reovirus infection. J. Virol;MR Duncan,1978
2. The preferential cytotoxicity of reovirus for certain transformed cell lines. Arch. Virol;G Hashiro,1977
3. Reovirus therapy of tumors with activated Ras pathway;MC Coffey;Science,1998
4. Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release. Mol. Ther;P Marcato,2007
5. Oncogenic Ras promotes reovirus spread by suppressing IFN-beta production through negative regulation of RIG-I signaling. Cancer Res;M Shmulevitz,2010